These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

971 related items for PubMed ID: 31678836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL, Andraka-Christou B, Attermann J, Cupito A, Buche J, Beck AJ.
    Subst Abuse Treat Prev Policy; 2020 Sep 14; 15(1):69. PubMed ID: 32928272
    [Abstract] [Full Text] [Related]

  • 3. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 4. Medications for management of opioid use disorder.
    Koehl JL, Zimmerman DE, Bridgeman PJ.
    Am J Health Syst Pharm; 2019 Jul 18; 76(15):1097-1103. PubMed ID: 31361869
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
    Gertner AK, Robertson AG, Jones H, Powell BJ, Silberman P, Domino ME.
    Health Serv Res; 2020 Jun 18; 55(3):383-392. PubMed ID: 32166761
    [Abstract] [Full Text] [Related]

  • 10. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
    Xu KY, Presnall N, Mintz CM, Borodovsky JT, Bhat NR, Bierut LJ, Grucza RA.
    JAMA Netw Open; 2021 Feb 01; 4(2):e210061. PubMed ID: 33625511
    [Abstract] [Full Text] [Related]

  • 11. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ.
    Pharmacotherapy; 2017 Jul 01; 37(7):824-839. PubMed ID: 28543191
    [Abstract] [Full Text] [Related]

  • 12. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM, Shoff C, Hodges K, Blanco C, Losby JL, Ling SM, Compton WM.
    JAMA Psychiatry; 2022 Oct 01; 79(10):981-992. PubMed ID: 36044198
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.
    Mintz CM, Presnall NJ, Xu KY, Hartz SM, Sahrmann JM, Bierut LJ, Grucza RA.
    Drug Alcohol Depend; 2021 Sep 01; 226():108886. PubMed ID: 34245997
    [Abstract] [Full Text] [Related]

  • 16. Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.
    Wang L, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R.
    J Clin Psychol; 2023 Dec 01; 79(12):2869-2883. PubMed ID: 37584532
    [Abstract] [Full Text] [Related]

  • 17. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP, Presnall N, Stringfellow E, Wood C, Horn P, Duello A, Green L, Rudder T.
    Am J Drug Alcohol Abuse; 2019 Dec 01; 45(4):333-340. PubMed ID: 31084515
    [Abstract] [Full Text] [Related]

  • 18. Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs.
    Krawczyk N, Maniates H, Hulsey E, Smith JS, DiDomenico E, Stuart EA, Saloner B, Bandara S.
    J Addict Med; 2019 Dec 01; 16(6):645-652. PubMed ID: 35165225
    [Abstract] [Full Text] [Related]

  • 19. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
    Tofighi B, El Shahawy O, Segoshi A, Moreno KP, Badiei B, Sarker A, Krawczyk N.
    J Addict Dis; 2021 Dec 01; 39(1):37-45. PubMed ID: 32835641
    [Abstract] [Full Text] [Related]

  • 20. Pronounced Regional Disparities in United States Methadone Distribution.
    Furst JA, Mynarski NJ, McCall KL, Piper BJ.
    Ann Pharmacother; 2022 Mar 01; 56(3):271-279. PubMed ID: 34184584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.